Definium Therapeutics, Inc. (DFTX) earnings
Quarterly results of Definium Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Definium Therapeutics, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Definium Therapeutics, Inc. reported revenue of - and a net loss of $51M.
Diluted earnings per share were -$0.46.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | - | - | -$51M | -$0.46 |
| Q2 FY2026 | - | - | -$159M | -$1.44 |
| Q1 FY2026 | - | - | -$77.1M | -$0.71 |
| Q4 FY2025 | - | - | -$50.4M | - |
| Q3 FY2025 | - | - | -$67.3M | -$0.78 |
| Q2 FY2025 | - | - | -$42.7M | -$0.50 |
| Q1 FY2025 | - | - | -$23.3M | -$0.35 |
| Q4 FY2024 | - | - | -$34.7M | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is Definium Therapeutics, Inc.'s next earnings date?
Definium Therapeutics, Inc. is expected to report around January 11, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when DFTX reports
Follow DFTX and we email you its next results the day they are filed, with the numbers explained.